Less Ads, More Data, More Tools Register for FREE

Pin to quick picksELTA.L Share News (ELTA)

  • There is currently no data for ELTA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Synthomer Believes Chair Right Man For Job Despite Shareholder Worries

Tue, 22nd Oct 2019 08:49

(Alliance News) - Synthomer PLC said Tuesday a significant minority of shareholders voted against the re-election of Chair Neil Johnson at the FTSE 250 chemical firm's recent annual general meeting, due to availability concerns.

Synthomer said 65% of shareholders voted to re-elect Johnson and, as a result, the company held discussions with significant shareholders who voted against him.

"The dialogue was initiated in order to better understand the reasons behind the dissenting votes," the company explained.

Following the discussions, Synthomer said the main concerns raised were over Johnson's "availability to devote sufficient time to carry out his responsibilities".

These issues arise from Johnson's chair role at two other London-listed companies: QinetiQ Group PLC and Electra Private Equity PLC.

"Whilst the board acknowledges that Neil's role as chairman of the QinetiQ board is a significant commitment which should be counted as such, this is not however considered to be the case with his chairmanship of Electra," said Synthomer.

The company believes, due to its managed wind-down, Electra requires "minimal input" from Johnson.

Sythomer added: "Accordingly, the board strongly believes that Neil is an effective chair with sufficient capacity to meet his commitments, and has no concerns over his availability to deal with company matters."

Shareholders also were concerned with Synthomer's lack of commitment to implement the Hampton-Alexander Review Recommendation - which aims to increase female representation on boards to 33% by the end of 2020.

"The board adopted its current policy on diversity in 2014 and has not recommended the setting of quotas for female or other representation," said Synthomer.

The company noted its two most recent board vacancies were filled by women, resulting in female representation of 22%.

"In order to address both the recommendation and the need for the refreshment of independent non-executive directors over the next 18 months in accordance with the provisions of the UK Corporate Governance Code, the board has decided to commit to the appointment of an additional female independent non-executive director by the end of 2020," the company said.

This will result in a short term increase in the size of Synthomer's board to 10, which is expected to reduce back to 9 in the first half of 2021.

Synthomer added: "It should be noted that the board has two long-standing male non-independent non-executive directors who are not subject to the tenure requirements of the code and who each continue to provide a highly valued contribution."

Shares in Synthomer were 0.4% lower in early trading in London on Tuesday at 300.64 pence each.

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
3 Feb 2017 07:04

Electra Private Equity to sell audio console manufacturing business

(ShareCast News) - Epiris, the portfolio manager of buyout fund Electra Private Equity, is to sell its Audiotonix business, which manufactures audio mixing consoles, to European private equity firm Astorg. From the sale, which is expected to close in the first quarter of 2017, Electra will receiv

Read more
30 Jan 2017 10:11

Electra Private Equity pockets £45m from Davies sale

(ShareCast News) - Epiris, the portfolio manager of buyout fund Electra Private Equity, has sold insurance claims service provider Davies Group to US-based private equity firm HGGC for £90m. Electra has received proceeds of £45m from the sale, which is a £2m uplift on the valuation of its investment

Read more
23 Dec 2016 09:27

BROKER RATINGS SUMMARY: HSBC Raises Electra Private Equity To Buy

Read more
23 Dec 2016 08:19

LONDON BRIEFING: Banks Probed, Fined And Bailed Out

Read more
20 Dec 2016 09:26

UPDATE 2-Canada's CCL to buy British bank note maker Innovia for $842 mln

* CCL buying Innovia from group of private equity firms * Electra Private Equity says makes 106 mln stg from sale * Innovia's polymer bank notes faces objections by vegetarians (Updates dateline, adds analyst comment, details from stake seller Electra, bullet points) By Aravin

Read more
20 Dec 2016 07:24

Electra's Espiris sells Innovia for $1.13bn

(ShareCast News) - Private equity outfit Electra, said on Tuesday its portfolio manager Epiris had sold Innovia Group, a manufacturer of speciality films and substrate for polymer banknotes to CCL Industries for an enterprise value of $1.13bn. Based on today's exchange rates, Electra would receive p

Read more
19 Dec 2016 07:45

UPDATE 1-Electra's manager Epiris to sell Parkdean Resorts for 1.35 bln stg

* To sell caravan holiday park firm to Onex Corporation * Electra to receive around 405 mln stg from sale * Internal rate of return on the deal around 46 pct (Adds details) By Noor Zainab Hussain Dec 19 (Reuters) - British buyout fund Electra Private Equity said its port

Read more
19 Dec 2016 07:27

Electra Private Equity bags £405m from caravan sites sale

(ShareCast News) - Electra Private Equity is due to receive roughly £405m proceeds from the £1.35bn sale of Parkdean Resorts to Canadian investors Onex Corporation. The sale of the caravan park owner, which is expected to complete on 1 March 2017, will see an uplift of £25m on Electra's book value i

Read more
19 Dec 2016 07:25

Electra's manager Epiris to sell Parkdean Resorts for 1.35 bln stg

Dec 19 (Reuters) - British buyout fund Electra Private Equity said its portfolio manager Epiris had agreed to sell Parkdean Resorts, an operator of caravan holiday parks, to private equity firm Onex Corporation for 1.35 billion pounds ($1.69 billion). The deal is expected to close in the f

Read more
9 Dec 2016 10:47

UPDATE 1-Electra posts bumper returns ahead of split from Epiris

(Adds detail, background) LONDON, Dec 9 (Reuters) - British buyout fund Electra Private Equity reported strong full-year returns on Friday as it prepares to cut ties with its portfolio manager Epiris. Electra said it made a return of 35 percent in diluted net asset value (NAV) per sha

Read more
9 Dec 2016 07:08

Electra Private Equity posts solid returns

(ShareCast News) - Electra Private Equity posted its preliminary results for the year to 30 September on Friday, with a net asset value per share of 5,149p, representing a total return of 35% for the year. The FTSE 250 firm's share price was 4,310p, a total return of 36% for the year, compared with

Read more
5 Dec 2016 14:35

Electra Partners renamed Epiris as tries to forge new future

By Dasha Afanasieva LONDON, Dec 5 (Reuters) - Buyout firm Electra Partners has renamed itself Epiris, aiming to forge a new future after being sacked as the portfolio manager for Electra Private Equity earlier this year. Epiris - a combination of EP for Electra Partners and "Iris", t

Read more
8 Nov 2016 08:11

Electra Private Equity to launch £200m share buyback

(ShareCast News) - Electra Private Equity said on Tuesday that it plans to return up to £200m to shareholders by a way of a tender offer. The company said the return of excess cash to shareholders should reduce the negative impact of holding this cash on growth in net asset value per ordinary share.

Read more
14 Oct 2016 07:28

Electra Private Equity to migrate to a corporate structure following review

(ShareCast News) - After a review of Electra Private Equity's investment strategy, policy and structure the company is to return control of all functions to the board in order to create value for shareholders, while switching to a corporate structure. Following on from the first phase of the review

Read more
7 Oct 2016 07:30

Electra Partners sells Vidal Group to M3 Inc

(ShareCast News) - Electra Partners' portfolio company AXIO Group has received a binding offer from M3 Inc. to purchase Vidal Group, a European provider of reference drug information for healthcare professionals, for €100m. The proposed transaction, which remains subject to certain conditions, would

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.